Aiming to enhance the eye care treatment, Sealdah Division of Eastern Railway has introduced Advanced OCT-A Technology at BR Singh Hospital.

The long-term benefits of endovascular thrombectomy (EVT) for basilar artery occlusion (BAO) in patients with low National ... classifications were defined as surrogates for comparing initial ...

Martin D, et al. Debate 3: Sustained drug delivery has a potential to be a significant treatment option for neovascular AMD and other retinal diseases. Presented at: Congress on Controversies in ...

In a now-deleted TikTok that raked in millions of views, Esther Jeong, from California, explained that she was recently injected with a collagen stimulant.

Aims Previous studies have suggested an association between retinal artery occlusion (RAO) and ischaemic stroke (IS), both associated with elevated inflammatory factors. However, the role of ...

Gill, MD, discusses the potential FDA approval in 2025 of aflibercept 8 mg for the treatment of retinal vein occlusion. Gill, vice chair of clinical performance and ophthalmology professor at ...

The application seeks to expand use of the treatment for patients ... 2% of the global population, while branch RVO affects anywhere from 0.5% to 2% of the population. 3 “With these pivotal results in ...

If approved, EYLEA HD would be the first and only treatment for RVO indicated ... including those with central retinal vein occlusion, branch retinal vein occlusion, or hemiretinal vein occlusion.

If approved, EYLEA HD would introduce the first treatment for RVO with a ... including those with central retinal vein occlusion, branch retinal vein occlusion, or hemiretinal vein occlusion.

If approved, Eylea would be the first treatment for RVO with 8-week dosing ... There are two main types of retinal vein occlusion: central retinal vein occlusion (CRVO) and branch retinal vein ...

The FDA's priority review of EYLEA HD targets macular edema post retinal vein occlusion and monthly dosing expansion. EYLEA HD's extended dosing intervals maintain efficacy, reducing treatment burden, ...